Rheos medicines stock

Related questions
Trends
Company profile page for Rheos Medicines Inc including stock price, company news, executives, board members, and contact information
Information on valuation, funding, cap tables, investors, and executives for Rheos Medicines. Use the PitchBook Platform to explore the full profile.
Rubius Therapeutics on Wednesday revealed plans to shut down and liquidate its assets, four years after it went public at a nearly $2 billion …
See Rheos Medicines funding rounds, investors, investments, exits and more. …
Fresh off Tilos Therapeutics’ $773 million sale to Merck, Fox is taking the helm of another Cambridge, Massachusetts-based company: Rheos Medicines.
Third Rock Ventures unwrapped its latest biotech baby this morning. The new company—Rheos Medicines—is focused on the emerging field of immunometabolism and makes its debut with $60 million...
Find company research, competitor information, contact details & financial data for Rheos …
Rheos Medicines - Developer of therapies for unmet immune-mediated …
Track the AUM, funds, and holdings for Rheos Medicines Inc over time. View the latest funds …
Discovery Company profile page for Rheos Medicines, Inc. including technical …
See more